Judges Scientific20 Sep 2023 12:40
Judges Scientific posted unaudited Interims for the HY ended 30th June this morning. Revenue was up 32% to £61.3m, adjusted pre-tax profit was up 33% to £12.8m and adjusted basic EPS was up 23% to 152.8p. However, there was a statutory loss per share of 18.7p mainly due to acquisition-related costs. The Board expects that the Group will meet market expectations for the full year, for top-line growth of about 9% and bottom-line growth of about 18%. Valuation remains the obvious cloud with forward PE ratio at 23.4x leaving JDG ranked 30th out of 31 names in the Machinery, Equipment & Components sector. The share price has been drifting sideways for the past 6 months as it consolidates its longer run gains. There is a lot to like here for the longer run, but JDG may be a share to monitor in the near term. ..
...from WealthOracle
wealthoracle.co.uk/detailed-result-full/JDG/802